Faculty

GSB faculty

The following faculty members from across the university play an active role in advancing Stanford's thought leadership in the healthcare sector.

Although these faculty members increasingly collaborate across schools at the university, they are listed below with their primary affiliation, along with their current research interests.

Laurence Baker (Medicine)
Improving the economic performance of the U.S. health care system; economics of health care technology diffusion.

Michele Barry (Medicine)
Clinical tropical medicine, emerging infectious diseases, problems of underserved populations, and globalization's impact upon health in the developing world and the global health workforce.

Mohsen Bayati (GSB)
Data-driven healthcare (predictive models, optimization, and decisions) through large-scale statistical data mining, machine learning, and probability theory.

Eran Bendavid (Medicine, SHP)
Understanding the relationship between policies and health outcomes in developing countries.

Jay Bhattacharya (Medicine)
Pharmaceutical economics; the effects of government policies designed to benefit vulnerable populations.

Kate Bundorf (Freeman Spogli Institute)
Health insurance markets including the determinants and effects of individual and purchaser choices, the effects of regulation in insurance markets, the interaction of public and private systems of health insurance, and incentives for insurers to improve health care quality.

Rob Chess (GSB)
The complex, real-world issues and trade-offs managers face in starting, growing, and operating companies in science and technology-based industries.

Alain Enthoven (GSB)
The failings of employment-based health insurance and proposals for market-based universal health insurance in the U.S.

Charles Jones (GSB)
Macroeconomic methods to study the economic causes behind the rise in health spending and longevity.

Riitta Katila (Engineering)
Innovation strategies in the biotechnology and medical devices sector.

Dan Kessler (GSB, Law)
The economics of health care and market-based solutions to the problems of the U.S. healthcare system.

Grant Miller (Medicine, SHP)
Behavioral obstacles to health improvement in developing countries.

Harikesh Nair (GSB)
The role of key opinion leaders in the diffusion and adoption of pharmaceuticals.

Sridhar Narayanran (GSB)
Understanding the behavior of physicians and consumers as it relates to new pharmaceutical products, and firm decisions.

Jim Patell (GSB)
Inexpensive solutions to healthcare needs of the developing world.

Robert Pearl (GSB)
Strategic thinking, strategic change, and leadership in healthcare.

Jeffrey Pfeffer (GSB)
Leadership in healthcare organizations and the health implications of poor management practices.

Hayagreeva Rao (GSB)
Developing and implementing new ideas in healthcare organizations (more information).

Peter Reiss (GSB)
Commercialization of science-based innovations and industrial organization in the healthcare sector.

Larry Wein (GSB)
Using mathematical models to analyze protocols for screening, treatment and perishable resource allocation.

Paul Yock (Engineering, Medicine, GSB)
Leadership development in biomedical technology innovation.

Ali Yurukoglu (GSB)
Industrial organizations and applying statistics to game theoretic models to study regulatory policy and imperfect competition.

Stefanos Zenios (PHI Faculty Director, GSB)
Innovations that improve access and reduce the cost of health care, and modeling of complex healthcare systems.